News

• US closes higher after Powell's speech
  05/17/2022 / 22:00 - TeleTrader
•  
• US opens higher ahead of Fed's interest rate decision
  05/04/2022 / 15:30 - TeleTrader
•  
• US markets open mixed ahead of Fed minutes
  04/04/2022 / 15:32 - TeleTrader
•  
• AMD to acquire Pensando for $1.9 billion
  04/04/2022 / 14:13 - TeleTrader
•  
• Pixium Vision announces FDA approval of clinical trial expansion of Prima System US feasibility study to Stanford Medicine
  03/29/2022 / 07:00 - GlobeNewswire
•  
• 4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights
  03/28/2022 / 22:02 - GlobeNewswire
•  
• Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30
  03/24/2022 / 07:00 - GlobeNewswire
•  
• AMD Instinct™ Expands Ecosystem and Delivers Exascale-Class Technology for HPC and AI Applications
  03/22/2022 / 14:00 - GlobeNewswire
•  
• Graybug Vision to Host Virtual R&D Day on March 30, 2022
  03/21/2022 / 21:30 - GlobeNewswire
•  
• Curative Biotechnology Announces Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration
  03/21/2022 / 14:50 - GlobeNewswire
•  
• 3rd Gen AMD EPYC Processors with AMD 3D V-Cache Technology Deliver Outstanding Leadership Performance in Technical Computing Workloads
  03/21/2022 / 14:00 - GlobeNewswire
•  
• Akari Therapeutics to Present on Two Ongoing Programs Covering Age-Related Macular Degeneration and Diseases of the Surface of the Eye at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting
  03/21/2022 / 13:00 - GlobeNewswire
•  
• Adverum Appoints Rabia Gurses Ozden, M.D. and Soo J. Hong, M.B.A., to Board of Directors
  03/17/2022 / 21:05 - GlobeNewswire
•  
• Introducing AMD Software: Adrenalin Edition 2022 Release and AMD FidelityFX Super Resolution 2.0 – Delivering High-Performance and Visually Stunning Gaming Experiences
  03/17/2022 / 14:00 - GlobeNewswire
•  
• Catalyst Biosciences Regains Rights to CB 2782-PEG for the Treatment of Dry AMD Expands CBIO’s Complement Portfolio in Ophthalmology
  03/15/2022 / 22:00 - GlobeNewswire